Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients with Advanced Gastric Cancer

Zachary R. McCaw; Ethan B. Ludmir; Lee Jen Wei

doi:10.1001/jamaoncol.2020.8002

Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients with Advanced Gastric Cancer

Zachary R. McCaw, Ethan B. Ludmir, Lee Jen Wei

GI Radiation Oncology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	632-633
Number of pages	2
Journal	JAMA Oncology
Volume	7
Issue number	4
DOIs	https://doi.org/10.1001/jamaoncol.2020.8002
State	Published - Apr 2021

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2020.8002

Cite this

@article{3481fea12e814e59ae78791b28d6b31b,

title = "Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients with Advanced Gastric Cancer",

author = "McCaw, {Zachary R.} and Ludmir, {Ethan B.} and Wei, {Lee Jen}",

year = "2021",

month = apr,

doi = "10.1001/jamaoncol.2020.8002",

language = "English (US)",

volume = "7",

pages = "632--633",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "4",

}

TY - JOUR

T1 - Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients with Advanced Gastric Cancer

AU - McCaw, Zachary R.

AU - Ludmir, Ethan B.

AU - Wei, Lee Jen

PY - 2021/4

Y1 - 2021/4

UR - http://www.scopus.com/inward/record.url?scp=85100700802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85100700802&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2020.8002

DO - 10.1001/jamaoncol.2020.8002

M3 - Letter

C2 - 33538772

AN - SCOPUS:85100700802

SN - 2374-2437

VL - 7

SP - 632

EP - 633

JO - JAMA Oncology

JF - JAMA Oncology

IS - 4

ER -

Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients with Advanced Gastric Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this